RESUMO
Background: Coronary artery diseases and therapies such as coronary angioplasty would lead to changes in the quality of life in patients. The aim of this study was to determine the effects of collaborative care model on the quality of life in patients after coronary angioplasty
Methods: This randomized controlled clinical trial was conducted in Isfahan, Iran during 2015. In this study, 50 samples were selected by simple sampling and randomly allocated into two equal groups of intervention and control. Collaborative care model was performed in the intervention group for 3 months. Data were collected using quality of life [SF-36] questionnaire which includes 36 questions on physical and psychological dimensions and was completed before and one month after the intervention in both groups. Data were analyzed using descriptive and analytical statistics and by independent t- test, paired t test, Chi square and Mann-Whitney tests through SPSS 18
Results: After the intervention, the mean score of quality of life in the intervention group was significantly higher than the control group [P<0.05]. The results of independent t-test showed a significant difference between both groups regarding the mean of changes in the score of quality of life and its dimensions in patients undergoing coronary angioplasty 3 months after the intervention [P<0.001]
Conclusion: Results revealed that patients who had been cared based on collaborative care model had better scores of quality of life in all the physical, mental and social dimensions than the control group. Therefore, using this model for taking care of patients after coronary angioplasty is recommended
RESUMO
Objective: to investigate the association between obesity indices, abdominal fat distribution, and lipid profile in patients with stable angina [SA]
Methods: body weight, height, waist circumference [WC], body mass index [BMI], and waist /height ratio [WHtR] of 123 patients with SA who underwent coronary angiography were measured. Fasting blood samples were taken to measure the levels of fasting blood sugar [FBS], total cholesterol [TC], low- and high-density lipoprotein cholesterol [LDL-C, HDL-C], apolipoproteins A and B [apo A and apo B], and triglycerides [TG]. According to angiography reports, the participants were divided into patients with or without coronary heart disease [CHD]. All patients underwent an abdominal computerized tomography [CT] scan to measure the visceral, superficial, and deep subcutaneous fat
Results: the mean ages of the patients with CHD [n = 73] and without CHD [n = 50] were 50.5 +/- 7.6 and 53.7 +/- 7.6 years, respectively [P = 0.03]. The patients with CHD had significantly higher levels of TC, TG, and superficial subcutaneous fat, while the patients without CHD had higher levels of apo A [P = 0.05]. Multivariate analyses showed a significant association of visceral fat with TC, LDL-C, TG, and apo B, in the patients without CHD, while significant inverse associations were found between WC and HDL-C, WHtR, and apo A as well as visceral fat and LDL-C in the patients with CHD
Conclusions: among anthropometrics and imaging indices of obesity, WC and WHtR have shown better association between central obesity with dyslipidemia in the patients with CHD, while CT-measured visceral adipose tissue area was the best correlate of dyslipidemia in the patients without CHD
RESUMO
Coronary artery disease is the most common cause of death worldwide. In patients with a history of MI, the risk of second myocardial infarction increases five-fold. This study aimed to investigate lifestyle habits, modifiable risk factors and medications in patients with coronary artery disease, as part of the first phase of Healthy Lifestyle for Cardiac Patients [HLCP] Project. In a cross-sectional study, patients with a definitive diagnosis of coronary artery disease during the past 6-12 months were studied. A questionnaire was filled to collect demographic details, past medical history, and all current medications. Blood pressure, height, weight, waist circumference, blood glucose and lipid profile were measured. Data was entered in SPSS 11 and analyzed via Student's t-test, chi square test and prevalence study. P values less than 0.05 were considered as significant. Of 427 patients, 41.5% were women. Mean blood pressure, waist circumference, fasting blood glucose, high-density lipoprotein cholesterol [HDL-C], low-density lipoprotein cholesterol [LDL-C], triglycerides and body mass index were higher in women, while total cholesterol, height and weight were higher in men. Mean 6- to 12-month cardiology visits were 6.34 and 6.88 for men and women, respectively. Despite these visits, the prevalence of diabetes mellitus, hypertension and high LDL-C was 19.1%, 18.4% and 88.6%, respectively. In addition to the considerable prevalence of modifiable risk factors, consumption of medications for secondary prevention and control of these factors were not sufficient; ACE-inhibitors and anti-platelet medications were used more frequently in men, while the use of other cardiac medications was higher in women [P<0.05]. Neither men nor women had optimal control of modifiable risk factors, and medications were not taken in adequate amounts by either men or women. We recommend that patients be given proper education to adopt healthy lifestyle habits, reduce risk factors and improve medication after discharge and in visits